Why Longevity Health Stock Is Skyrocketing Today
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jul 15 2025
0mins
Should l Buy ?
Source: Benzinga
Merger Announcement: Longevity Health Holdings Inc's shares surged after announcing a definitive all-stock merger with True Health Inc, following the termination of a previous merger with 20/20 BioLabs. The new deal aims to enhance bioaesthetic innovation through plasma synergies.
Stock Performance: Following the merger news, Longevity Health's stock price increased by 115.50% to $5.70, with a notable 52-week high of $59.10 and a low of $2.20, indicating significant market interest in the company's future prospects.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
